KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ambev (ABEV) Payables (2016 - 2025)

Historic Payables for Ambev (ABEV) over the last 15 years, with Q3 2025 value amounting to $3.5 billion.

  • Ambev's Payables fell 1346.32% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 1346.32%. This contributed to the annual value of $6.0 billion for FY2024, which is 1545.74% up from last year.
  • As of Q3 2025, Ambev's Payables stood at $3.5 billion, which was down 1346.32% from $4.2 billion recorded in Q2 2025.
  • Over the past 5 years, Ambev's Payables peaked at $6.0 billion during Q4 2024, and registered a low of $3.5 billion during Q3 2025.
  • In the last 5 years, Ambev's Payables had a median value of $4.4 billion in 2022 and averaged $4.4 billion.
  • Its Payables has fluctuated over the past 5 years, first soared by 2438.18% in 2022, then crashed by 1391.79% in 2023.
  • Quarter analysis of 5 years shows Ambev's Payables stood at $4.8 billion in 2021, then rose by 3.37% to $4.9 billion in 2022, then grew by 6.89% to $5.3 billion in 2023, then grew by 14.54% to $6.0 billion in 2024, then tumbled by 41.06% to $3.5 billion in 2025.
  • Its Payables was $3.5 billion in Q3 2025, compared to $4.2 billion in Q2 2025 and $4.5 billion in Q1 2025.